Tuesday, August 18, 2009

Lilly will not seek FDA approval for arzoxifene - The Associated Press


Lilly will not seek FDA approval for arzoxifene
The Associated Press
Shares of Eli Lilly lapse 34 cents to $32.50 in after-hours trading. The stock ended the regular conference up 13 cents at $32.84.

and more »

No comments:

Post a Comment